MetLife, Inc. vs Wells Fargo & Company — Stock Comparison
Q·Score Breakdown
6.1
Hold
Overall
7.1
Buy
Quality
Health
Growth
Valuation
Sentiment
MET
67% of 18 covering analysts rate it Buy or Strong Buy.
⚠ negative free cash flow.
WFC
Trading at an attractive 10.4× forward earnings.
Analyst Consensus
BUY
Target $89.06 (+10.9%)
16 analysts
BUY
Target $96.65 (+18.1%)
23 analysts
Fundamentals
MET
WFC
17.0×
Trailing P/E
12.6×
7.3×
Forward P/E
10.4×
4.4%
Profit Margin
26.7%
23.4%
Gross Margin
0.0%
12.0%
ROE
12.0%
27.6%
Revenue Growth
5.7%
-34.2%
Earnings Growth
15.1%
0.73
Beta
1.06
—
Price / Book
—
$52.4B
Market Cap
$250.7B
$67 – $84
52-Week Range
$70 – $98
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.